BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 2699909)

  • 1. [Autologous bone marrow transplantation--a new approach in the treatment of neoplastic hematologic diseases. I. Scientific principles and methodology of the treatment].
    Nemet D
    Lijec Vjesn; 1989 Dec; 111(12):466-74. PubMed ID: 2699909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of neoplastic hematologic diseases with intensive radio-chemotherapy and transplantation of cryopreserved autologous bone marrow].
    Nemet D; Labar B; Bogdanić V; Kolevska T; Mrsić M; Pavletić Z; Kalenić S; Vrtar M; Marusić M; Markulin-Grgić L
    Lijec Vjesn; 1989; 111(9-10):348-53. PubMed ID: 2633014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous bone marrow transplantation for leukemia.
    Stuart RK
    Semin Oncol; 1993 Oct; 20(5 Suppl 6):40-54. PubMed ID: 8211215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Indications for bone marrow and peripheral stem cell transplantation in malignant hematological diseases].
    Gratwohl A
    Ther Umsch; 1996 Feb; 53(2):152-7. PubMed ID: 8629266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Technical aspects of autologous bone marrow transplantation].
    Handgretinger R; Klingebiel T; Niethammer D
    Infusionsther Transfusionsmed; 1994 Nov; 21 Suppl 3():39-41. PubMed ID: 7841779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour cell purging for autologous bone marrow transplantation.
    Trickett AE
    Med Lab Sci; 1990 Apr; 47(2):120-31. PubMed ID: 2199741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibody-purged autologous bone marrow transplantation in adults with acute lymphoblastic leukemia at high risk of relapse.
    Soiffer RJ; Roy DC; Gonin R; Murray C; Anderson KC; Freedman AS; Rabinowe SN; Robertson MJ; Spector N; Pesek K
    Bone Marrow Transplant; 1993 Sep; 12(3):243-51. PubMed ID: 8241984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic bone marrow transplantation in the treatment of hematologic diseases.
    Yee GC; McGuire TR
    Clin Pharm; 1985; 4(2):149-60. PubMed ID: 3886273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term cryopreservation of bone marrow for autologous transplantation.
    Attarian H; Feng Z; Buckner CD; MacLeod B; Rowley SD
    Bone Marrow Transplant; 1996 Mar; 17(3):425-30. PubMed ID: 8704699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes.
    Slavin S; Naparstek E; Nagler A; Ackerstein A; Kapelushnik J; Or R
    Exp Hematol; 1995 Dec; 23(14):1553-62. PubMed ID: 8542946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic and autologous bone marrow transplantation for acute nonlymphocytic leukemia.
    Hurd DD
    Semin Oncol; 1987 Dec; 14(4):407-15. PubMed ID: 3321445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous bone marrow transplantation in acute leukemia.
    Gorin NC
    J Natl Cancer Inst; 1986 Jun; 76(6):1281-7. PubMed ID: 2940400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hematopoietic stem cell transplantation for treatment of acute leukemia].
    Harada M
    Gan To Kagaku Ryoho; 1999 Sep; 26(10):1387-95. PubMed ID: 10500524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autologous bone marrow transplantation for hematologic cancer.
    Phillips GL
    Prog Clin Biol Res; 1990; 354B():171-84. PubMed ID: 2236163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in both the hematopoietic microenvironment and the progenitor cell population follow the recovery from myeloablative therapy and bone marrow transplantation.
    Novitzky N; Mohamed R
    Exp Hematol; 1995 Dec; 23(14):1661-6. PubMed ID: 8542962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Autografts of bone marrow and current role of cytokines in hematology].
    Gorin NC
    C R Seances Soc Biol Fil; 1993; 187(4):452-86. PubMed ID: 7912642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Autologous bone marrow transplantation].
    Klingebiel T; Handgretinger R; Niethammer D
    Infusionsther Transfusionsmed; 1994 Nov; 21 Suppl 3():42-5. PubMed ID: 7841780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Indications, technique and risks in bone marrow transplantation in adulthood].
    Heyll A; Söhngen D; Minning H; Meckenstock G; Aul C; Schneider W
    Praxis (Bern 1994); 1996 Mar; 85(12):378-86. PubMed ID: 8643901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antileukemic effect of interleukin-2-transduced murine bone marrow after autologous transplantation.
    Tam YK; Klingemann HG
    Biol Blood Marrow Transplant; 1999; 5(4):231-42. PubMed ID: 10465103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.